British National Formulary June 2024 Update

This update contains 10 significant changes, 9 dose changes, 5 new monographs and 3 deleted monographs.

Significant Changes:

Antibacterials, use for prophylaxis: addition of antibacterial prophylaxis guidance for assisted vaginal birth (ventouse or forceps).
Borderline substances: products suitable for conditions requiring a ketogenic diet have been moved to a new section called Ketogenic diet.
Diabetic hyperglycaemic emergencies: updated guidance for management of individuals aged 16-18 years.
Immunisation schedule: updated guidance for herpes zoster (shingles) immunisation.
Meningococcal vaccines: updated guidance for immunisation.
Metformin hydrochloride: new indication and dose for type 1 diabetes mellitus.
Obstetrics: updated guidance for the prevention and treatment of haemorrhage.
Prescribing in renal impairment: update to CKD-EPI equation to remove race.
Sacubitril with valsartan: update to dose expression.
Varicella-zoster vaccines: updated guidance for immunisation against herpes zoster (shingles).

Dose Changes:

Bexsero® (meningococcal group B vaccine (rDNA, component, adsorbed)) [update to dosing].
Carbetocin [update to indication and dose].
Cyanocobalamin [update to dosing].
Ergometrine maleate [update to dosing for postpartum haemorrhage caused by uterine atony].
Ergometrine with oxytocin [update to dosing for active management of the third stage of labour].
Haemophilus influenzae type b with meningococcal group C vaccine [update to dosing].
Herpes-zoster vaccine (recombinant, adjuvanted) [update to dosing].
Meningococcal groups A with C and W135 and Y vaccine [update to dosing].
Oxytocin [update to dosing for active management of the third stage of labour].

New Monographs:

Deleted Monographs: